As per MRFR analysis, the Ureteral Stents Market Size was estimated at 0.53 (USD Billion) in 2024. The Ureteral Stents Market Industry is expected to grow from 0.56 (USD Billion) in 2025 to 0.92 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.72% during the forecast period (2025 - 2034).Growing incidence of kidney diseases, rising burden of urological disorders and rising product approvals by regulatory authorities are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The growing incidence of kidney diseases has a significant impact on the ureteral stents market. Kidney diseases such as kidney stones, urinary tract infections, tumors, and other urological disorders often require the placement of a ureteral stent. A ureteral stent is a flexible, hollow tube that is inserted into the ureter to help urine flow from the kidney to the bladder. Ureteral stents are used to treat a variety of conditions, including kidney stones, tumors, and strictures. The increasing prevalence of kidney diseases, particularly kidney stones, is one of the key drivers of the ureteral stents market. According to a report by the National Kidney Foundation, kidney stones affect about one in ten people at some point in their lives, and the incidence of kidney stones has been increasing over the past few decades. In addition, the increasing aging population is also contributing to the growth of the ureteral stents market. As people age, they are more likely to develop urological disorders that require the use of ureteral stents. Moreover, technological advancements in ureteral stent design and materials have also driven the growth of the ureteral stents market CAGR. These advancements have led to the development of stents with improved durability, biocompatibility, and ease of insertion, which has made them more attractive to both patients and healthcare providers.
Rising prevalence of kidney diseases is projected to propel worldwide ureteral stents market to expand during the projection period. For instance, the United States Renal Data System (USRDS) reports that there are around 786,000 people in the country who have end-stage renal disease (ESRD), of whom 71% require dialysis and 29% a kidney transplant. In the United States, 131,636 people have received an ESRD diagnosis in 2018, a 2.3% increase from 2017. Unadjusted ESRD incidence per million grew by 1.5% between 2017 and 2018, however adjusted ESRD incidence per million increased by just 0.2%. Also, According to USRDS Coordinating Center (CC), 14.9% of the adult population in the United States that were surveyed during 2015 and 2018 had chronic kidney disease (CKD) based on a low eGFR or proteinuria (on a single examination). According to the same organization, in 2018, the number of End-Stage Renal Disease (ESDR) incidents reported were 1,31,112 and in 2019, the number reached 1,34,608. which is anticipated to fuel significant growth of ureteral stents market revenue.
The ureteral stents market segmentation, based on type, includes Double Pigtail Ureteral Stent, Others. The double pigtail ureteral stent segment held the majority share in 2022 contribution to significant share in respect to the ureteral stents market revenue. This is primarily owing to growth in urological diseases and obstruction, a strong demand for stents with minimal migration, and basis of growth of cutting-edge stents with few disadvantages. Also, a number of actions done by the government and healthcare organizations also contribute to the market's expansion.
The ureteral stents market segmentation, based on material, includes metallic stents, polymers stents, others. The metallic stents segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the metallic ureteral stents' resistance toward being encrusted with stone material. As a result, stent change procedures are performed less frequently and dwelling durations are extended. Also, using a metallic ureteral stent for benign ureteral obstruction results in lower overall procedural costs than using a polymer stent. Hence, rising demand of metal material implants for ureteral stents positively impacts the market growth.
The ureteral stents market data has been bifurcated by treatment into Kidney Stones, Kidney Transplant, Others. The kidney stones segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The adoption of a sedentary lifestyle and dietary trends that cause urolithiasis are two factors that are fueling the expansion of this market segment. For instance, a 2018 study published in the NCBI predicted that over 600,000 Americans get urinary stones each year. The need for ureteral stent during ureteroscopy and ureterorenoscopy, among other operations used to treat kidney stones, is what is causing the segment to grow.
Figure 1: Ureteral Stents Market, by Treatment, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Based on End Users, the ureteral stents industry has been segmented into hospitals, nephrological centers, ambulatory surgical centers. Multispecialty hospitals held the largest segment share in 2022, due to the geriatric population's preference for hospital treatments, as all related treatments are carried out under one roof. In addition, hospitals perform a greater number of surgical procedures and rising government investment in hospital sector is anticipated to support the market growth.
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Ureteral Stents market accounted for USD 0.22 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing presence of Key market players like Boston Scientific Company, Medline Industries, and Coloplast are present and helping to drive expansion in the area. In addition, raising government healthcare spending opens up new business opportunities.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: URETERAL STENTS MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe ureteral stents market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, growing prevalence of chronic kidney disease, rising aging population, and growing government investment in healthcare development. Further, the Germany ureteral stents market held the largest market share, and the UK ureteral stents market was the fastest growing market in the European region
The Asia-Pacific Ureteral Stents Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to increased rates of osteoarthritis and degenerative disc disease, the rapidly growing medical tourism industry, and rising healthcare costs. Moreover, China ureteral stents market held the largest market share, and the India ureteral stents market was the fastest growing market in the Asia-Pacific region.
Major market players are spending a lot of money on R&D to increase their product lines, which will help the ureteral stents market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the ureteral stents industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the ureteral stents industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, ureteral stents industry has provided treatment with some of the most significant benefits. The ureteral stents market major player such as Boston Scientific (US), Cook Medical (US), Allium Medical (Israel), and others are working to expand the market demand by investing in research and development activities.
The Boston Scientific Corporation was established in year 1979 and its headquarters is in Marlborough, Massachusetts, United States. The company is a medical device developer, producer, and marketer with products used in a variety of interventional medical specialties. Cardiovascular and cardiac rhythm management (CRM) products are the company's key products. Electrophysiology, pain treatment (neuromodulation), endoscopy, pelvic health, and urology are among the devices it produces. Biopsy forceps, coronary and urethral stents, catheters, defibrillators, pacemakers and needles are some of the company's diagnostic and treatment products. The company globally provides its products and services in more than 120 countries. The employee size of the company is 10,001+ employees. In June 2022, for its Tria Ureteral Stent, the first stent built with a patented surface technology intended to give protection against the accumulation from both urine calcium and magnesium salt deposits, Boston Scientific has been honoured with a Bronze Edison Award in the field of Science and Medicine.
Also, Allium Medical was established in year 2008 and its headquarters is in Haeshel St, Caesarea, Israel. The company develops, produces, and markets cutting-edge, long-lasting, fully covered, expandable, and retrievable stents for the treatment of various blockages in the GI and urinary tracts on a scale. In contrast to the usual practise of surgery or short-term solutions, Allium's distinctive stent solutions offer a less invasive, reversible alternative approach. With its extensive proven experience and usage, Allium is paving the way for patients and doctors to provide the next level of patient care. In May 2018, The China Food and Drug Administration (CFDA) has granted Allium Medical, an Israeli medical device firm that specialises in minimally invasive technologies and solutions, permission to commercialise its range of urology systems in China. In the Chinese urology sector, the company has an exclusive strategic partnership with a distribution company.
May 2022:The United States Food and Drug Administration approved 510k clearance for a new urinary stent generated by Dean Secrest and Lee Ponsky, MD, the Chair of the Department of Urology and Leo and Charlotte Goldberg, Chair in Advanced Surgeons Therapies at University Hospitals (UH) in Cleveland.
April 2019:The Stone Management Ureteral Stent and the Axis single-use digital flexible ureter scope are new products from Dornier Med Tech. This stent will aid in lowering cross-contamination among patients in the same operating room by giving a clean and sterile ureteroscope for each single use.
Double Pigtail Ureteral Stent
Others
Metallic Stents
Polymers Stents
others
Kidney Transplant
Others
Hospitals
Nephrological Centers
Ambulatory Surgical Centers
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Attribute/Metric | Details |
| Market Size 2024 | Â Â 0.53 (USD Billion) |
| Market Size 2025 | Â Â 0.56 (USD Billion) |
| Market Size 2034 | Â Â 0.92 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | Â Â 5.72 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Material, Treatment, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Boston Scientific (US), Cook Medical (US), C.R. Bard (US), B. BRAUN (Germany), Olympus (Japan), Coloplast (Denmark), Allium Medical (Israel), Teleflex Incorporated (US), Biomerics (Italy), Medline industries inc. (US) |
| Key Market Opportunities | Rising Investment in healthcare sector |
| Key Market Dynamics | Rising incidence of kidney diseases Increasing product approvals by regulatory authorities |
Ureteral Stents Market Highlights:
Frequently Asked Questions (FAQ) :
The ureteral stents market size was valued at USD 0.48 Billion in 2022.
The market is projected to grow at a CAGR of 5.72% during the forecast period, 2025 - 2034
North America had the largest share in the market
The key players in the market are Boston Scientific (US), Cook Medical (US), C.R. Bard (US), B. BRAUN (Germany), Olympus (Japan), Coloplast (Denmark), Allium Medical (Israel), Teleflex Incorporated (US), Biomerics (Italy), Medline industries inc. (US).
The Double Pigtail Ureteral Stent category dominated the market in 2022.
The Kidney Stones had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
